May 26, 2016 2:51 AM ET

Biotechnology

Company Overview of Ultragenyx Pharmaceutical Inc.

Executive Profile

William E. Aliski

Independent Director, Chairman of Compensation Committee and Member of Audit Committee, Ultragenyx Pharmaceutical Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 6 different industries.

See Board Relationships
69$460,159

Background

Mr. William E. Aliski, also known as Bill served as the Chief Commercial Officer and Senior Vice President of FoldRx Pharmaceuticals, Inc. Mr. Aliski has wealth of experience advancing novel therapies for the treatment of orphan diseases to market. He has over 25 years experience in the biotechnology industry, with the majority of that time focused on the orphan drug market. Prior to FoldRx Pharmaceuticals, he served as Senior Director of Simon Kucher Partners, a global ...

Corporate Headquarters

60 Leveroni Court
Novato, California 94949

United States

Phone: 415-483-8800
Fax: 415-483-8810

Board Members Memberships

2011-Present
Independent Director, Chairman of Compensation Committee and Member of Audit Committee
2013-Present
Independent Director
2013-Present
Director

Education

Master's Degree
Harvard University
BS
Boston College
Master's Degree
Boston College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$50,000
Total Calculated Compensation$460,159
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ultragenyx Pharmaceutical Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.